Title : The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.

Pub. Date : 2017 Jul 20

PMID : 28319060






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. Exenatide glucagon-like peptide 1 receptor Mus musculus
2 Exenatide (Ex-4), a potent diabetes drug targeting glucagon-like peptide-1 receptor (GLP-1R), is protective against non-alcoholic fatty liver disease (NAFLD). Exenatide glucagon-like peptide 1 receptor Mus musculus
3 Exenatide (Ex-4), a potent diabetes drug targeting glucagon-like peptide-1 receptor (GLP-1R), is protective against non-alcoholic fatty liver disease (NAFLD). Exenatide glucagon-like peptide 1 receptor Mus musculus